Bronchodilators are medications that relax airway smooth muscle or reduce constricting neural tone so narrowed bronchi and bronchioles open. They improve airflow in asthma, COPD, chronic bronchitis, emphysema, bronchospasm, and reactive airway disease. The clinical significance is immediate: a small increase in airway diameter sharply lowers airflow resistance, reduces wheeze and dyspnea, improves expiratory flow, and decreases work of breathing. Bronchodilators do not replace anti-inflammatory therapy when airway inflammation is the driver; they treat airway narrowing and symptoms while the broader plan addresses inflammation, triggers, infection, or chronic remodeling. On the exam, writers often pair stable-sounding options with unstable data—notice the mismatch before you commit. If the stem names a license or role, reread that line; scope errors are classic trap answers even when the clinical topic is familiar. Run a 60-second scan: breathing work and oxygenation, perfusion and end organs, neuro baseline, likely infection sources, and devices that can fail quietly. When two answers feel partly right, pick the one that reduces imminent harm and matches orders for the role you were given. Train yourself to state the **primary...